Nebulizers

Named the AMS-H-03, this is a hydrogen-oxygen nebulizer that can help relieve the shortage of ventilators, highlighting the potential of hydrogen-oxygen therapy in tackling COVID-19.

The class III medical respiratory device can produce three liters of mixed gas containing hydrogen and oxygen by using water electrolysis and can run continuously for 24 hours

The hydrogen oxygen nebulizer uses water electrolysis to produce three liters of mixed gas containing 66.66% hydrogen and 33.33% oxygen. Hydrogen, the smallest molecular gas in the atmosphere, can replace nitrogen to transport oxygen into the alveoli of the lungs. 

 The device can improve the symptoms of chest pain, dyspnea, shortness of breath, cough, sputum and violent pneumonia in patients. In addition, it can reduce the risk of severe illness, shorten the length of hospital stay, and help patients to improve pulmonary fibrosis.

Hydrogen’s powerful anti-inflammatory effect can prevent the acute inflammation caused by the virus and the concomitant multi-organ dysfunction. The hydrogen oxygen nebulizer, used to treat patients ith mild to severe symptoms, has the potential to become one of the most vital adjuvant therapies in the global fight against the epidemic.

The device can be used alone or in combination via a trident joint. It can be also used in parallel with oxygen pipelines, invasive ventilators and non-invasive ventilators in hospitals.